A therapeutic genome editing primer for cardiologist
نویسندگان
چکیده
منابع مشابه
A genome editing primer for the hematologist.
Gene editing enables the site-specific modification of the genome. These technologies have rapidly advanced such that they have entered common use in experimental hematology to investigate genetic function. In addition, genome editing is becoming increasingly plausible as a treatment modality to rectify genetic blood disorders and improve cellular therapies. Genome modification typically ensues...
متن کاملGenetics Primer for the General Cardiologist
Not all patients respond to drug therapy in a uniform and beneficial fashion. The goal of this review is to describe the contribution of genetic variation to drug response, with a focus on drugs used in cardiovascular therapy. Genetic approaches used to analyze rare and common adverse effects as well as variability in efficacy are presented first. The challenges and potential solutions to incor...
متن کاملA Simple Genome Walking Strategy to Isolate Unknown Genomic Regions Using Long Primer and RAPD Primer
Background: Genome walking is a DNA-cloning methodology that is used to isolate unknown genomic regions adjacent to known sequences. However, the existing genome-walking methods have their own limitations. Objectives: Our aim was to provide a simple and efficient genome-walking technology. Material and Methods: In this paper, we dev...
متن کاملIn Vivo Delivery Systems for Therapeutic Genome Editing
Therapeutic genome editing technology has been widely used as a powerful tool for directly correcting genetic mutations in target pathological tissues and cells to cure of diseases. The modification of specific genomic sequences can be achieved by utilizing programmable nucleases, such as Meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and ...
متن کاملThe therapeutic potential of genome editing for β-thalassemia.
The rapid advances in the field of genome editing using targeted endonucleases have called considerable attention to the potential of this technology for human gene therapy. Targeted correction of disease-causing mutations could ensure lifelong, tissue-specific expression of the relevant gene, thereby alleviating or resolving a specific disease phenotype. In this review, we aim to explore the p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiogenetics
سال: 2018
ISSN: 2035-8148,2035-8253
DOI: 10.4081/cardiogenetics.2018.7262